AGR is a subsidiary of Bumrungrad International Hospital Public Company Limited (SET:BH), based in Bangkok, Thailand. Through its CRO and SMO business segments, the company offers a broad range of Phase I to IV clinical trials and staffing. AGR will help establish clinical trial in Southeast Asia, with its diverse patient populations, as an ideal location for rigorous, insightful and cost-effective outsourcing clinical research.

AGR’s trial management capabilities include establishing and monitoring trials in Thailand.

The Clinical Research Organization (CRO) is staffed with research professionals who possess many years of experience managing clinical trials in the global environment. This highly trained group is fully capable of managing complete development programs or any individual service required by a sponsor.

The Site Management Organization (SMO) is made up of personnel who use their years of experience in conducting site studies for the international pharmaceutical industry. This staff evaluates and recruits hospital and clinics which meet the ICH-GCP standards required for producing rapid enrolment and quality data.

History of AGR:

2006 Mahidol University, a leading medical university in Thailand,
         established International Drug Development (IDD) Co., Ltd. as subsidiary.

2008 Bumrungrad Hospital International acquired IDD and changed name to
         Asia Global Research Co., Ltd.

2009 AGR provided CRO, SMO and Medical marketing services to customers